Global Health


Improving care globally

We provide people with access to adequate high-quality healthcare, for example:

  • We improved access to better therapies in diabetes, cancer, hypertension, and fertility in underserved regions through the company's Capacity Advancement Program
  • We strengthened the group's Global Health Institute to accelerate R&D, incorporate access provisions and build capacity
  • We conduct awareness campaigns e.g. for diabetes, thyroid disorders and cancer
Best Practice

Transparency on patents to insure public health meeds: Pat-INFORMED initiative recognized as a best practice in the 2018 Access to Medicine Index

#gutstrength

Colorectal Cancer Awareness Month campaign #gutstrength reached 162,000 people

Preventing and treating infectious diseases

  • We aim to eliminate the worm disease schistosomiasis
    • Since 2007, we have donated over 1 billion praziquantel tablets to WHO for distribution across 46 nations in Africa
    • We support the NALA Foundation with a Schistosomiasis Health Education Project targeting 850,000 people in Ethiopia
    • We are developing a pediatric formulation of praziquantel for children under the age of six (Phase III study will be implemented in 2019)
  • We help delivering integrated and sustainable health solutions against malaria (treatments, diagnostics, prevention methods)
  • New compound is being developed as a single-dose combination to treat and potentially prevent malaria in children (Phase I study underway since 2017)

Read more

Redirect

You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement